These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33883498)

  • 1. Multimodal Imaging in a Patient With Alzheimer Disease and Parkinsonism Because of a Presenilin-1 Mutation.
    Lu JY; Sun YM; Yen TC; Zuo CT; Wang J
    Clin Nucl Med; 2021 Sep; 46(9):e483-e484. PubMed ID: 33883498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A heterozygous de novo PSEN1 mutation in a patient with early-onset parkinsonism.
    Chen Y; Liu P; Xie F; Wang B; Lin Z; Luo W
    Neurol Sci; 2022 Feb; 43(2):1405-1409. PubMed ID: 34843019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopa Responsive Parkinsonism in an Early Onset Alzheimer's Disease Patient with a Presenilin 1 Mutation (A434T).
    Jo H; Kim M; Park S; Park JE; Cho SH; Kim SJ; Jang H; Jung YH; Kim J; Na DL; Seo SW; Cho JW; Kim HJ
    J Alzheimers Dis; 2019; 71(1):7-13. PubMed ID: 31322578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSEN1 G417S mutation in a Chinese pedigree causing early-onset parkinsonism with cognitive impairment.
    Jiang L; Qin Y; Zhao YW; Zeng Q; Pan HX; Liu ZH; Sun QY; Xu Q; Tan JQ; Yan XX; Li JC; Tang BS; Guo JF
    Neurobiol Aging; 2022 Jul; 115():70-76. PubMed ID: 35489321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel presenilin 1 mutation (Leu418Trp) associated with spasticity, parkinsonism, and white matter lesion in a dominant Alzheimer's family.
    Takahashi Y; Ohta Y; Sasaki R; Tadokoro K; Sato K; Shang J; Takemoto M; Hishikawa N; Yamashita T; Haraguchi T; Ikeuchi T; Abe K
    J Neurol Sci; 2018 Apr; 387():166-169. PubMed ID: 29571857
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel mutation in PSEN1 (p.Arg41Ser) in an Argentinian woman with early onset Parkinsonism.
    Gatto EM; Rojas GJ; Nemirovsky SI; Da Prat G; Persi G; Cesarini M; Etcheverry JL; Rojas NG; Parisi V; Cordoba M; Sevlever G; Allegri RF; Turjanski AG
    Parkinsonism Relat Disord; 2020 Aug; 77():21-25. PubMed ID: 32590294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation.
    Carecchio M; Picillo M; Valletta L; Elia AE; Haack TB; Cozzolino A; Vitale A; Garavaglia B; Iuso A; Bagella CF; Pappatà S; Barone P; Prokisch H; Romito L; Tiranti V
    Neurogenetics; 2017 Jul; 18(3):175-178. PubMed ID: 28664294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain 18 F-Florbetapir PET/CT Findings in an Early-onset Alzheimer Disease Patient Carrying Presenilin-1 G378E Mutation.
    Cistaro A; Quartuccio N; Cassalia L; Vai D; Guerra UP; Atzori C; Rainero I; Imperiale D
    Alzheimer Dis Assoc Disord; 2022 Oct-Dec 01; 36(4):347-349. PubMed ID: 34132671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer's disease.
    Norton DJ; Parra MA; Sperling RA; Baena A; Guzman-Velez E; Jin DS; Andrea N; Khang J; Schultz A; Rentz DM; Pardilla-Delgado E; Fuller J; Johnson K; Reiman EM; Lopera F; Quiroz YT
    Alzheimers Res Ther; 2020 Aug; 12(1):99. PubMed ID: 32825838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease.
    Franzmeier N; Düzel E; Jessen F; Buerger K; Levin J; Duering M; Dichgans M; Haass C; Suárez-Calvet M; Fagan AM; Paumier K; Benzinger T; Masters CL; Morris JC; Perneczky R; Janowitz D; Catak C; Wolfsgruber S; Wagner M; Teipel S; Kilimann I; Ramirez A; Rossor M; Jucker M; Chhatwal J; Spottke A; Boecker H; Brosseron F; Falkai P; Fliessbach K; Heneka MT; Laske C; Nestor P; Peters O; Fuentes M; Menne F; Priller J; Spruth EJ; Franke C; Schneider A; Kofler B; Westerteicher C; Speck O; Wiltfang J; Bartels C; Araque Caballero MÁ; Metzger C; Bittner D; Weiner M; Lee JH; Salloway S; Danek A; Goate A; Schofield PR; Bateman RJ; Ewers M
    Brain; 2018 Apr; 141(4):1186-1200. PubMed ID: 29462334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare causes of dystonia-parkinsonism with cognitive impairment, behavioral abnormalities, and voiceless whispering stereotypies: Describing the long-term evolution of the neurological phenotype in a patient with the PSEN2 Ile149Thr variant.
    Romito LM; Prioni S; Braccia A; Catania M; Elia AE; Dondi F; Lucchini S; Bertagna F; Piacentini SHMJ; Eleopra R; Di Fede G
    J Neurol Sci; 2023 Nov; 454():120846. PubMed ID: 38236755
    [No Abstract]   [Full Text] [Related]  

  • 13. Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study.
    Fleisher AS; Chen K; Quiroz YT; Jakimovich LJ; Gomez MG; Langois CM; Langbaum JB; Ayutyanont N; Roontiva A; Thiyyagura P; Lee W; Mo H; Lopez L; Moreno S; Acosta-Baena N; Giraldo M; Garcia G; Reiman RA; Huentelman MJ; Kosik KS; Tariot PN; Lopera F; Reiman EM
    Lancet Neurol; 2012 Dec; 11(12):1057-65. PubMed ID: 23137949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer's disease-causing Presenilin-1 E280A mutation carriers.
    Ghisays V; Lopera F; Goradia DD; Protas HD; Malek-Ahmadi MH; Chen Y; Devadas V; Luo J; Lee W; Baena A; Bocanegra Y; Guzmán-Vélez E; Pardilla-Delgado E; Vila-Castelar C; Fox-Fuller JT; Hu N; Clayton D; Thomas RG; Alvarez S; Espinosa A; Acosta-Baena N; Giraldo MM; Rios-Romenets S; Langbaum JB; Chen K; Su Y; Tariot PN; Quiroz YT; Reiman EM;
    Neuroimage Clin; 2021; 31():102749. PubMed ID: 34252876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic Variability in Autosomal Dominant Familial Alzheimer Disease due to the S170F Mutation of Presenilin-1.
    Tiedt HO; Benjamin B; Niedeggen M; Lueschow A
    Neurodegener Dis; 2018; 18(2-3):57-68. PubMed ID: 29466804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation.
    Ringman JM; Gylys KH; Medina LD; Fox M; Kepe V; Flores DL; Apostolova LG; Barrio JR; Small G; Silverman DH; Siu E; Cederbaum S; Hecimovic S; Malnar M; Chakraverty S; Goate AM; Bird TD; Leverenz JB
    Neurosci Lett; 2011 Jan; 487(3):287-92. PubMed ID: 21094210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characterization of a presenilin 1 mutation (F177S) in a family with very early-onset Alzheimer's disease in the third decade of life.
    Hausner L; Tschäpe JA; Schmitt HP; Hentschel F; Hartmann T; Frölich L
    Alzheimers Dement; 2014 Mar; 10(2):e27-39. PubMed ID: 23850332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study.
    Thordardottir S; Rodriguez-Vieitez E; Almkvist O; Ferreira D; Saint-Aubert L; Kinhult-Ståhlbom A; Thonberg H; Schöll M; Westman E; Wall A; Eriksdotter M; Zetterberg H; Blennow K; Nordberg A; Graff C
    Alzheimers Res Ther; 2018 May; 10(1):45. PubMed ID: 29747683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/MRI Delivers Multimodal Brain Signature in Alzheimer's Disease with De Novo PSEN1 Mutation.
    Aghakhanyan G; Saur D; Rullmann M; Weise CM; Schroeter ML; Marek K; Jamra RA; Tiepolt S; Strauss M; Scherlach C; Hoffmann KT; Sabri O; Classen J; Barthel H
    Curr Alzheimer Res; 2021; 18(2):178-184. PubMed ID: 33855944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β.
    Therriault J; Benedet AL; Pascoal TA; Mathotaarachchi S; Chamoun M; Savard M; Thomas E; Kang MS; Lussier F; Tissot C; Parsons M; Qureshi MNI; Vitali P; Massarweh G; Soucy JP; Rej S; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P
    JAMA Neurol; 2020 Apr; 77(4):470-479. PubMed ID: 31860000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.